Find stats on top websites
Industry Landscape
The digital health industry is experiencing robust growth, driven by increasing adoption of telehealth, wearable technologies, and AI-powered solutions. Focus areas include chronic disease management, mental health, and personalized care. Regulatory frameworks are evolving to support innovation while ensuring patient safety and data privacy. Investment remains strong, reflecting confidence in its potential to transform healthcare delivery.
Total Assets Under Management (AUM)
Digital Health Market Size in United States
~250 Billion USD
(27.5% CAGR)
- Telemedicine accounts for a significant portion.
- Growth in remote monitoring and chronic care management.
- Increasing adoption of digital therapeutics.
Total Addressable Market
250 billion USD
Market Growth Stage
Pace of Market Growth
Emerging Technologies
Generative AI for Personalized Content
Generative AI can create highly personalized therapeutic content, coping strategies, and educational materials tailored to individual patient needs and real-time emotional states.
Wearable Biometric Integration
Integrating data from wearables (e.g., heart rate, sleep patterns, activity levels) allows for real-time health monitoring and proactive, data-driven interventions and personalized recommendations.
Virtual Reality (VR) for Immersion Therapy
VR can provide immersive therapeutic experiences for pain management, anxiety reduction, and mindfulness, offering a new dimension to digital mental wellness solutions.
Impactful Policy Frameworks
21st Century Cures Act (2016) - Digital Health Provisions
This act includes provisions to accelerate the discovery, development, and delivery of 21st-century cures, which includes provisions for digital health, streamlining regulatory pathways for certain low-risk digital health tools and encouraging interoperability.
The Cures Act has generally fostered an environment supportive of digital health innovation by clarifying regulatory pathways, potentially making it easier for Elly Health to introduce new features and products without overly burdensome regulatory hurdles, while also emphasizing data sharing.
Information Blocking Rule (2020), ONC's Cures Act Final Rule
Effective April 5, 2021, this rule prohibits healthcare providers, IT developers, and health information exchanges from engaging in practices that interfere with the access, exchange, or use of electronic health information (information blocking).
This rule promotes greater data interoperability and patient access to their health information, which could facilitate Elly Health's partnerships with providers and health systems by ensuring smoother data exchange for integrated care.
FDA's Digital Health Software Precertification Program (Ongoing Pilot)
While not a formal regulation yet, the FDA's Digital Health Software Precertification (Pre-Cert) Program, initiated in 2017 and currently a pilot, aims to develop a tailored regulatory oversight for software as a medical device (SaMD) based on a company's organizational excellence and product quality.
If formalized, this program could significantly streamline the regulatory approval process for Elly Health's more clinically oriented digital therapeutics, potentially accelerating market entry for new offerings.
Transform Your Ideas into Action in Minutes with WaxWing
Sign up now and unleash the power of AI for your business growth
